Sign In
Buy MYL
$15.86
+0 (+0%)
At Close: May 27, 2022
Hope dims for hydroxychloroquine even as medical study detailing the drug’s failure is retracted
04:48pm, Friday, 05'th Jun 2020
A month ago, about 70% of the COVID-19 patients being treated at the 13 hospitals that make up the Hackensack Meridian Health system in New Jersey received hydroxychloroquine as part of their care.
Don’t Judge Pfizer by Its Vaccine Efforts
03:59pm, Friday, 05'th Jun 2020
A lot of stocks are rising because of efforts to find a cure or vaccine against COVID-19. Pfizer's (NYSE:PFE) PFE stock should not be one of them.Source: Manuel Esteban / Shutterstock.com That's not t
Interim Results Of U.K. Trial Of Hydroxychloroquine Show No Evidence Of Benefit In Hospitalized COVID-19 Patients
01:41pm, Friday, 05'th Jun 2020Hope dims for hydroxychloroquine even as medical study detailing the drug’s failure is retracted
07:22pm, Thursday, 04'th Jun 2020
A month ago, about 70% of the COVID-19 patients being treated at the 13 hospitals that make up the Hackensack Meridian Health system in New Jersey received hydroxychloroquine as part of their care.
Mylan and Lupin Receive European Marketing Authorization For Nepexto, Biosimilar Etanercept
12:07pm, Thursday, 04'th Jun 2020Mylan and Lupin Receive European Marketing Authorization for Nepexto®, Biosimilar Etanercept
12:00pm, Thursday, 04'th Jun 2020
Mylan N.V. (NASDAQ: MYL) and Lupin Limited (Lupin) today announced that the European Commission (EC) has granted marketing authorization for Nepexto®, a biosimilar to Enbrel® (etanercept), for all i
Hydroxychloroquine No Better Than Placebo In Preventing Infection With The Conroavirus, University Of Minnesota Study Shows
07:26pm, Wednesday, 03'rd Jun 2020Shares Of Mylan, Teva Ticking Lower As Dow Jones Reports 'Antimalaria Drug Didn't Protect Against Covid-19 In Latest Large Study'
07:03pm, Wednesday, 03'rd Jun 2020'Antimalaria Drug Didn't Protect Against Covid-19 In Latest Large Study'
07:02pm, Wednesday, 03'rd Jun 2020'WHO says hydroxychloroquine coronavirus trials to resume' -AFP Tweet
04:14pm, Wednesday, 03'rd Jun 2020Is Momenta Pharmaceuticals' Stock a Buy?
12:08pm, Wednesday, 03'rd Jun 2020
Despite disruptions from the COVID-19 pandemic, Momenta Pharmaceuticals' (NASDAQ: MNTA) clinical trials investigating experimental therapies for a variety of autoimmune conditions and rare diseases ar
Delaware Enhanced Global Dividend and Income Fund Announces Distributions
09:05pm, Tuesday, 02'nd Jun 2020
Today, Delaware Enhanced Global Dividend and Income Fund (the "Fund"), a New York Stock Exchange–listed closed-end fund trading under the symbol "DEX," declares a monthly distribution of $0.0485 per
Revance, Mylan Move Forward With Botox Rival; Analyst Sees Long Path Ahead
07:31am, Tuesday, 02'nd Jun 2020
After several postponed decisions, Mylan Inc (MYL) has announced that it is moving forward with a Botox biosimilar development program in collaboration with Revance Therapeutics (RVNC). On the news MY
